CLINICAL_TRIALS
trial_result
· 2011-01-26
Clinical Trial Update: UK Study Assessing Flexible Dose Fesoterodine in Adults [Phase 4]
Summary
Pfizer completed a Phase 4 UK study evaluating flexible-dose fesoterodine in adults with overactive bladder; results were posted in January 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED | Results posted: 2011-01-26